Publikationen, an denen er mitarbeitet Alfonso Manuel Soto Moreno (3)

2024

  1. Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study)

    Nutrients, Vol. 16, Núm. 15

  2. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

    The Lancet, Vol. 404, Núm. 10454, pp. 773-786

2023

  1. Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study

    Frontiers in Endocrinology, Vol. 14